Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 14 Rectal Neoplasms 13 Colonic Neoplasms 10 Esophageal Neoplasms 5 Stomach Neoplasms 4 Rhabdomyosarcoma 4 Pancreatic Neoplasms 4 Neuroblastoma 4 Central Nervous System Neoplasms 4 Adenocarcinoma Of Esophagus 4 Sarcoma 3 Neoplasm Metastasis 3 Medulloblastoma 3 Lung Neoplasms 3 Wilms Tumor 2 Unspecified Childhood Solid Tumor, Protocol Specific 2 Sarcoma, Ewing 2 Ovarian Neoplasms 2 Optic Nerve Glioma 2 Oligodendroglioma 2 Malignant mesenchymal tumor 2 Fibrolamellar hepatocellular carcinoma 2 Familial ependymoma 2 Esophageal Squamous Cell Carcinoma 2 Choroid Plexus Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Trabectedin 1 Polymerase Chain Reaction 1 Pharmacogenomic Testing 1 PM 01183 1 Mass Spectrometry 1 Irinotecan 1 Glutamine 1 Gene Expression Profiling 1 Doxorubicin 1 Chromatography, High Pressure Liquid 1 Base Sequence 1 BI 2536 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Desmoplastic Small Round Cell Tumor × Irinotecan × Clear all

NCT07328425 2026-04-03

ISG-TULIPS

Italian Sarcoma Group

Phase 2 Recruiting

Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡